Palaniappan LP, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2026 Heart Disease and Stroke statistics: a report of US and Global Data From the American Heart Association. Circulation. 2026;153(9):e275–906. https://doi.org/10.1161/CIR.0000000000001412.
Bath PM, Song L, Silva GS, Mistry E, Petersen N, Tsivgoulis G, et al. Blood Pressure Management for Ischemic Stroke in the First 24 Hours. Stroke. 2022;53(4):1074–84. https://doi.org/10.1161/STROKEAHA.121.036143.
Article PubMed PubMed Central Google Scholar
McManus M, Liebeskind DS. Blood pressure in acute ischemic stroke. J Clin Neurol. 2016;12(2):137–46. https://doi.org/10.3988/jcn.2016.12.2.137.
Article PubMed PubMed Central Google Scholar
Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Hussein HM, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25(1):32–8. https://doi.org/10.1016/j.ajem.2006.07.008.
Article PubMed PubMed Central Google Scholar
Xie X, Zhong C, Liu X, Pan Y, Wang A, Wei Y, et al. Early versus delayed antihypertensive treatment after acute ischemic stroke by hypertension history. Stroke. 2025;56(3):631–9. https://doi.org/10.1161/STROKEAHA.124.049242.
Article PubMed CAS Google Scholar
Aries MJ, Elting JW, De Keyser J, Kremer BP, Vroomen PC. Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke. 2010;41(11):2697–704. https://doi.org/10.1161/STROKEAHA.110.594168.
Reinhard MRS, Hetzel A. Cerebral autoregulation in acute ischemic stroke. Perspect Med. 2012;1:194–7. https://doi.org/10.1016/j.permed.2012.02.028.
Gorelick PB, Qureshi S, Farooq MU. Management of blood pressure in stroke. Int J Cardiol Hypertens. 2019;3:100021. https://doi.org/10.1016/j.ijchy.2019.100021.
Article PubMed PubMed Central Google Scholar
Jordan JD, Powers WJ. Cerebral autoregulation and acute ischemic stroke. Am J Hypertens. 2012;25(9):946–50. https://doi.org/10.1038/ajh.2012.53.
Oliveira-Filho J, Silva SC, Trabuco CC, Pedreira BB, Sousa EU, Bacellar A. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology. 2003;61(8):1047–51. https://doi.org/10.1212/01.WNL.0000092498.75010.
Article PubMed CAS Google Scholar
Bangalore S, Schwamm L, Smith EE, Hellkamp AS, Suter RE, Xian Y, et al. Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke. Eur Heart J. 2017;38(37):2827–35. https://doi.org/10.1093/eurheartj/ehx330.
Article PubMed PubMed Central Google Scholar
Hao Z, Liu M, Wang D, Wu B, Tao W, Chang X. High blood pressure on admission in relation to poor outcome in acute ischemic stroke with intracranial atherosclerotic stenosis or occlusion. J Stroke Cerebrovasc Dis. 2014;23(6):1403–8. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.11.025.
Leonardibee J, Bath PM, Phillips SJ, Sandercock PA, Group ISTC. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33(5):1315–20. https://doi.org/10.1161/01.str.0000014509.11540.66.
Kang J, Ko Y, Park JH, Kim WJ, Jang MS, Yang MH, et al. Effect of blood pressure on 3-month functional outcome in the subacute stage of ischemic stroke. Neurology. 2012;79(20):2018–24. https://doi.org/10.1212/WNL.0b013e3182749eb8.
Article PubMed PubMed Central Google Scholar
Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke. 2022;53(7):e282–361. https://doi.org/10.1161/STR.0000000000000407.
Article PubMed CAS Google Scholar
Prabhakaran S, Gonzalez NR, Zachrison KS, Adeoye O, Alexandrov AW, Ansari SA, et al. 2026 Guideline for the early management of patients with acute ischemic stroke: a guideline from the American Heart Association/American Stroke Association. Stroke. 2026. Published online January 26, 2026. https://doi.org/10.1161/STR.0000000000000513.
Vemmos KN, Tsivgoulis G, Spengos K, Zakopoulos N, Synetos A, Manios E, et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med. 2004;255(2):257–65. https://doi.org/10.1046/j.1365-2796.2003.01291.x.
Article PubMed CAS Google Scholar
Visvanathan A, Dennis M, Whiteley W. Parenteral fluid regimens for improving functional outcome in people with acute stroke. Cochrane Database Syst Rev. 2015;2015(9):CD011138. https://doi.org/10.1002/14651858.CD011138.pub2.
Article PubMed PubMed Central Google Scholar
Strømsnes TA, Kaugerud Hagen TJ, Ouyang M, Wang X, Chen C, Rygg SE, et al. Pressor therapy in acute ischaemic stroke: an updated systematic review. Eur Stroke J. 2022;7(2):99–116. https://doi.org/10.1177/23969873221078136.
Article PubMed PubMed Central Google Scholar
Rosenfeldt Z, Conklen K, Jones B, Ferrill D, Deshpande M, Siddiqui FM. Comparison of nicardipine with clevidipine in the management of hypertension in acute cerebrovascular diseases. J Stroke Cerebrovasc Dis. 2018;27(8):2067–73. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.03.001.
Vitt JR, Trillanes M, Hemphill JC 3rd. Management of Blood Pressure During and After Recanalization Therapy for Acute Ischemic Stroke. Front Neurol. 2019;10:138. https://doi.org/10.3389/fneur.2019.00138.
Article PubMed PubMed Central Google Scholar
Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282(21):2019–26. https://doi.org/10.1001/jama.282.21.2019.
Article PubMed CAS Google Scholar
Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–29. https://doi.org/10.1056/NEJMoa0804656.
Article PubMed CAS Google Scholar
Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274(13):1017–25.
Article PubMed CAS Google Scholar
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352(9136):1245–51. https://doi.org/10.1016/s0140-6736(98)08020-9.
Article PubMed CAS Google Scholar
National Institute of Neurological D, Stroke rt PASSG. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333(24):1581–7. https://doi.org/10.1056/NEJM199512143332401.
Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11–20. https://doi.org/10.1056/NEJMoa1411587.
Article PubMed CAS Google Scholar
Bracard S, Ducrocq X, Mas JL, Soudant M, Oppenheim C, Moulin T, et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial. Lancet Neurol. 2016;15(11):1138–47. https://doi.org/10.1016/S1474-4422(16)30177-6.
Article PubMed CAS Google Scholar
Brott TG, Haley EC Jr., Levy DE, Barsan W, Broderick J, Sheppard GL, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke. 1992;23(5):632–40. https://doi.org/10.1161/01.str.23.5.632.
Comments (0)